top of page
News & Updates from McGivney Global
Search
Oncologists, McGivney Weigh in on Value Frameworks
Prior to the ICER meeting to review evidence and vote on cost-effectiveness ratings for NSCLC treatments, five prominent oncologists...
McGivney Global
Oct 25, 20161 min read
Comments on the Recent Institute for Clinical and Economic Review (ICER) Meeting
I have extensive experience in “real world” policy-setting and decision-making and I am puzzled about the motivations regarding the...
McGivney Global
Oct 25, 20162 min read
Impact of Oncology Value Metrics
McGivney Global Advisors publishes quarterly reports assessing the changes and impact of Oncology Value Metrics, including NCCN Evidence...
McGivney Global
Jul 11, 20161 min read
Health Insurers Behaving Badly...
Will a spate of recent lawsuits shift the balance of power in the health care industry? While no companies in the health care industry...
McGivney Global
Jul 8, 20164 min read
McGA work on ICER cited by BIO
A McGivney Global Advisors op-ed on Oncology Value Metrics and ICER was referenced by the Biotechnology Industry Organization, quoting...
McGivney Global
Jun 16, 20161 min read
bottom of page